Literature DB >> 26123702

NF-κB decoy oligodeoxynucleotide inhibits wear particle-induced inflammation in a murine calvarial model.

Taishi Sato1, Jukka Pajarinen1, Tzu-hua Lin1, Yasunobu Tamaki2, Florence Loi1, Kensuke Egashira3, Zhenyu Yao1, Stuart B Goodman1,4.   

Abstract

Wear particles induce periprosthetic inflammation and osteolysis through activation of nuclear factor kappa B (NF-κB), which up-regulates the downstream target gene expression for proinflammatory cytokines in macrophages. It was hypothesized that direct suppression of NF-κB activity in the early phases of this disorder could be a therapeutic strategy for preventing the inflammatory response to wear particles, potentially mitigating osteolysis. NF-κB activity can be suppressed via competitive binding with double stranded NF-κB decoy oligodeoxynucleotides (ODNs) that blocks this transcription factor from binding to the promoter regions of targeted genes. In this murine calvarial study, clinically relevant polyethylene particles (PEs) with/without ODN were subcutaneously injected over the calvarial bone. In the presence of PE particles, macrophages migrated to the inflammatory site and induced tumor necrosis factor alpha (TNF-α) and receptor activator of nuclear factor kappa B ligand (RANKL) expression, resulting in an increase in the number of osteoclasts. Local injections of ODN mitigated the expression of TNF-α, RANKL, and induced the expression of two anti-inflammatory, antiresorptive cytokines: interleukin-1 receptor antagonist and osteoprotegerin. Local intervention with NF-κB decoy ODN in early cases of particle-induced inflammation in which the prosthesis is still salvageable may potentially preserve periprosthetic bone stock.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  NF-κB; murine calvarial model; osteolysis; total joint replacement; wear particles

Mesh:

Substances:

Year:  2015        PMID: 26123702      PMCID: PMC4817851          DOI: 10.1002/jbm.a.35532

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  23 in total

1.  Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signaling in periprosthetic osteolysis.

Authors:  E M Schwarz; A P Lu; J J Goater; E B Benz; G Kollias; R N Rosier; J E Puzas; R J O'Keefe
Journal:  J Orthop Res       Date:  2000-05       Impact factor: 3.494

Review 2.  Guidelines for assessment of bone microstructure in rodents using micro-computed tomography.

Authors:  Mary L Bouxsein; Stephen K Boyd; Blaine A Christiansen; Robert E Guldberg; Karl J Jepsen; Ralph Müller
Journal:  J Bone Miner Res       Date:  2010-07       Impact factor: 6.741

3.  Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis.

Authors:  J Jeffrey Goater; Regis J O'Keefe; Randy N Rosier; J Edward Puzas; Edward M Schwarz
Journal:  J Orthop Res       Date:  2002-03       Impact factor: 3.494

Review 4.  Current concepts: immunology. Monocytes and macrophages.

Authors:  R B Johnston
Journal:  N Engl J Med       Date:  1988-03-24       Impact factor: 91.245

5.  IL-1 mediates TNF-induced osteoclastogenesis.

Authors:  Shi Wei; Hideki Kitaura; Ping Zhou; F Patrick Ross; Steven L Teitelbaum
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

6.  Selective blockade of NF-kappa B activity in airway immune cells inhibits the effector phase of experimental asthma.

Authors:  Christophe Desmet; Philippe Gosset; Bernard Pajak; Didier Cataldo; Mohamed Bentires-Alj; Pierre Lekeux; Fabrice Bureau
Journal:  J Immunol       Date:  2004-11-01       Impact factor: 5.422

7.  NF-kB signaling blockade abolishes implant particle-induced osteoclastogenesis.

Authors:  John C Clohisy; Teruhisa Hirayama; Elfaridah Frazier; Suk-Ku Han; Yousef Abu-Amer
Journal:  J Orthop Res       Date:  2004-01       Impact factor: 3.494

8.  New treatment of periodontal diseases by using NF-kappaB decoy oligodeoxynucleotides via prevention of bone resorption and promotion of wound healing.

Authors:  Hideo Shimizu; Hironori Nakagami; Shosuke Morita; Ikuyo Tsukamoto; Mariana Kiomy Osako; Futoshi Nakagami; Takashi Shimosato; Noriko Minobe; Ryuichi Morishita
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

Review 9.  Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases.

Authors:  Lorenz C Hofbauer; Michael Schoppet
Journal:  JAMA       Date:  2004-07-28       Impact factor: 56.272

10.  Wear particles, periprosthetic osteolysis and the immune system.

Authors:  Stuart B Goodman
Journal:  Biomaterials       Date:  2007-07-23       Impact factor: 12.479

View more
  12 in total

Review 1.  Immunobiology of periprosthetic inflammation and pain following ultra-high-molecular-weight-polyethylene wear debris in the lumbar spine.

Authors:  John H Werner; John H Rosenberg; Kristen L Keeley; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2018-08-21       Impact factor: 4.473

2.  Orthopaedic wear particle-induced bone loss and exogenous macrophage infiltration is mitigated by local infusion of NF-κB decoy oligodeoxynucleotide.

Authors:  Tzuhua Lin; Jukka Pajarinen; Akira Nabeshima; Luis A Córdova; Florence Loi; Emmanuel Gibon; Laura Lu; Karthik Nathan; Eemeli Jämsen; Zhenyu Yao; Stuart B Goodman
Journal:  J Biomed Mater Res A       Date:  2017-09-13       Impact factor: 4.396

3.  NF-κB decoy oligodeoxynucleotide mitigates wear particle-associated bone loss in the murine continuous infusion model.

Authors:  Tzu-Hua Lin; Jukka Pajarinen; Taishi Sato; Florence Loi; Changchun Fan; Luis A Córdova; Akira Nabeshima; Emmanuel Gibon; Ruth Zhang; Zhenyu Yao; Stuart B Goodman
Journal:  Acta Biomater       Date:  2016-05-31       Impact factor: 8.947

4.  * Murine Model of Progressive Orthopedic Wear Particle-Induced Chronic Inflammation and Osteolysis.

Authors:  Jukka Pajarinen; Akira Nabeshima; Tzu-Hua Lin; Taishi Sato; Emmanuel Gibon; Eemeli Jämsen; Laura Lu; Karthik Nathan; Zhenyu Yao; Stuart B Goodman
Journal:  Tissue Eng Part C Methods       Date:  2017-11-13       Impact factor: 3.056

Review 5.  Diagnosis and management of implant debris-associated inflammation.

Authors:  Stuart B Goodman; Jiri Gallo; Emmanuel Gibon; Michiaki Takagi
Journal:  Expert Rev Med Devices       Date:  2019-12-17       Impact factor: 3.166

6.  Suppression of NF-κB-induced chronic inflammation mitigates inflammatory osteolysis in the murine continuous polyethylene particle infusion model.

Authors:  Takeshi Utsunomiya; Ning Zhang; Tzuhua Lin; Yusuke Kohno; Masaya Ueno; Masahiro Maruyama; Ejun Huang; Claire Rhee; Zhenyu Yao; Stuart B Goodman
Journal:  J Biomed Mater Res A       Date:  2021-03-28       Impact factor: 4.396

7.  Dicalcium Silicate Induced Proinflammatory Responses through TLR2-Mediated NF-κB and JNK Pathways in the Murine RAW 264.7 Macrophage Cell Line.

Authors:  Shixiang Lai; Liangjiao Chen; Wei Cao; Shiman Cui; Xingyang Li; Wenchao Zhong; Mingyu Ma; Qingbin Zhang
Journal:  Mediators Inflamm       Date:  2018-05-02       Impact factor: 4.711

Review 8.  Inflammation and Bone Repair: From Particle Disease to Tissue Regeneration.

Authors:  Stuart B Goodman; Jukka Pajarinen; Zhenyu Yao; Tzuhua Lin
Journal:  Front Bioeng Biotechnol       Date:  2019-09-19

Review 9.  Periprosthetic Osteolysis: Mechanisms, Prevention and Treatment.

Authors:  Stuart B Goodman; Jiri Gallo
Journal:  J Clin Med       Date:  2019-12-01       Impact factor: 4.241

Review 10.  Modulation of the Inflammatory Response and Bone Healing.

Authors:  Masahiro Maruyama; Claire Rhee; Takeshi Utsunomiya; Ning Zhang; Masaya Ueno; Zhenyu Yao; Stuart B Goodman
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-11       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.